Introduction
The efficiency of the presentation of exogenous antigen by effective antigen presentation (3) (4) (5) . More recently, glycosphingolipids including GM 1 have also been implicated (6) . MHC II ϩ antigen-presenting cells (APC) is determined by the presence of specific cell receptors, the endocytic activity,
In association with sphingomyelin and cholesterol, GM 1 is concentrated in cell membranes in caveolae-like structures targeting of antigen to compartments of antigen processing and the initial form of the antigen (1,2). Moreover, the simple in lymphocytes and in caveolae in other cells (6, 7) . Crosslinking of GM 1 by antibodies or by proteins such as cholera binding of antigens to selected cell-surface molecules may also affect the outcome of antigen presentation or the generatoxin induces the formation of membrane rafts and capping (8, 9) ; these membrane domains appear to play roles in tion of the subsequent immune response. Understanding the pathway of antigen processing and the mechanisms by membrane sorting, signal transduction and cell adhesion (6) . Ganglioside GM 1 is the main receptor for Escherichia coli which antigen binding enhances processing will be useful in designing vaccination strategies or to modulate autoimmune enterotoxin (Etx) and the structurally and functionally related cholera toxin (Ctx) from Vibrio cholerae. These are oligomeric diseases.
A number of cell surface receptors including, Ig, transferrin A-B toxins composed of an enzymatic part (A subunit) with ADP-ribosyltransferase activity and a pentameric binding receptor, FcγR and DEC-205 can mediate endocytosis and domain (B subunit) responsible for binding the toxins to Methods mammalian cells (10). Etx binds with high affinity to GM 1 Animals and immunization (K d ϭ 7.3ϫ10 -10 ), but has also been reported to bind weakly to asialo-GM 1 and GD 1b (11) . Binding of the toxins to cells BALB/c (Harlan-Olac, Bicester, UK) and NIH (NIH, Bethesda, involves the exposed carbohydrate and sialic acid moieties MD) mice (8-10 weeks old) were used. For immunization, of GM 1 ; GM 1 is anchored to the membrane by its ceramide mice were injected i.p. 100 µg of EtxB emulsified in incomplete tail (12).
Freund's adjuvant. Between 10 and 14 days later mesenteric Binding to GM 1 on immune cells may explain some of the lymph nodes (MLN) were dissected out. previously reported immunological properties of Etx and Ctx. Both toxins are potent immunogens in vivo (13, 14) . The B Antigens subunits alone mediate several of the immunological proper-A Gly33 → Asp substitution was introduced into the GM 1 ties of Etx and Ctx (15-17), but, importantly, are devoid of binding site of EtxB (18). Recombinant human EtxB and any toxic activity. Thus, administration of small amounts of the mutant protein, EtxB (G33D) , were purified as reported EtxB or CtxB in the absence of any additional adjuvant elicits previously (30) . Identical physical and chemical properties strong antibody responses in both mice (18,19) and humans were found for both antigens (18). Briefly, these included (20). In vitro, Ctx and CtxB are strongly inhibitory for lymphostability in SDS gels, retention time as analysed by highcyte proliferation (21, 22) , although this effect is not seen with resolution gel filtration chromatography, stability in low pH EtxB (18). Both Ctx and Etx can activate APC in vitro.
buffers and binding to a panel of antibodies. However, when For example, Ctx increases MHC class II expression and compared with EtxB, EtxB (G33D) showed a highly significant promotes isotype-switch differentiation in B cells (23, 24) . Prior reduction in binding to GM 1 (Ͼ99% reduction in the A 450 treatment of peritoneal macrophages with either Ctx or CtxB reading on microtiter plates) and failed to bind a number of enhanced subsequent presentation of native hen egg lysocells, including mouse B lymphocytes (31 and this study) and syme (HEL) and HEL peptides to 3A9 T cell hybridomas T cells (T. O. Nashar, unpublished). The crystal structure in vitro (25) . Ctx increases the expression of B7-2 on bone of EtxB (G33D) revealed that it had the same overall threemarrow-derived macrophages (26) and peritoneal macrodimensional structure as wild-type EtxB (32) . Two techniques phages respond with increased secretion of IL-1 (27).
were used to measure lipopolysaccharide (LPS) content in Although it is likely that some of these effects are related to the protein preparations including enhanced silver staining the ability of these toxins to bind GM 1 on the APC, no direct (33) and an enzymatic assay, kinetic QCL lysate kit evidence has been presented. Interpretation of some of these (Biowhitaker, Walkersville, MD). Using silver staining no LPS results is also complicated by the presence of the A subunit was detected. QCL lysate kit detected very small, but comparthat causes an increase of intracellular cyclic AMP. able amounts of LPS, 2 ng/10 µg of protein in either EtxB or (34) . Biotin-EtxB and PC-OVA conjugates were added to cells on ice at 1 and 100 µg/ml respectively. Cells were CD4 ϩ T cells and B220 ϩ cells were isolated from MLN and incubated initially on ice for 20 min to allow binding, then for spleen respectively. Cell suspensions were recovered and an additional 20, 60 or 120 min at 37°C. PC-OVA was added incubated with MACS antibody-conjugated magnetic beads to cells in the last 20 min following incubation of EtxB on ice. and then fractionated on columns according to instructions When PC-OVA was not used, cells were incubated with EtxB supplied by the manufacturer. Splenic B cells were positively for 20 min at 37°C. The remaining antigens were washed off, selected with anti-B220 antibody. MLN CD4 ϩ T cells were and cells were homogenized and ruptured as described positively selected with anti-CD4 antibody-conjugated beads. (34, 35 In all the experiments above, proliferation was measured achieved when cells were allowed to adhere to plastic during following addition of 1 µCi/well of [ 3 H]thymidine (Amersham, incubation with antigens and subsequently washed (see Little Chalfont, UK) in the last 6 h before harvesting (Mach III below). This procedure ensured that the majority of lymphoharvesting 96; Tomtec, Orange, CT) and counting by standard cytes and other non-adherent cells present in culture were liquid scintillation (1450 Microbeta Plus; LKB-Wallac, Turku, removed before addition of T cells.
Fractionation of various cell populations
Finland).
Assays for binding of EtxB and EtxB (G33D) on surface of B cells
Antigen presentation by CD11c ϩ DC Splenic B220 ϩ cells were isolated by positive selection, as MACS purified CD11c ϩ cells were resuspended in complete described above. Cells (6ϫ10 5 ) were re-suspended in HBSS medium to which 0.5% fresh MAS added. To establish cell (Sigma, St Louis, MO) containing 0.2% azide (to stop culture, 10 5 CD11c ϩ cells were pulsed with 0.1, 0.5 and internalization) and incubated on ice with increasing doses 1 µg/ml of either EtxB or EtxB (G33D) for 2 h. Adherent cells of either EtxB or EtxB (G33D) for 20 min. Cells were then were washed inside wells and then incubated with 1ϫ10 6 /ml incubated with rabbit anti-EtxB antibody for 30 min on ice.
of purified CD4 ϩ T cells isolated from mice injected with EtxB This was followed by addition of biotinylated (FabЈ) 2 goat in incomplete Freund's adjuvant. In similar experiments where anti-rabbit IgG for 30 min and ExtrAvidin-FITC conjugate for kinetics of proliferation in these cultures was determined, the an additional 15 min. Cells were then analysed by flow maximum level occurred on day 4. On the latter day, triplicate cytometry. samples of 0.1 ml of cells were removed from the cultures Assays for EtxB internalization and sub-cellular fractionation and pulsed with 1 µCi/well of [ 3 H]thymidine (Amersham) of B cells for 6 h before harvesting and counting by standard liquid scintillation. A20µWT cells transfected with phosphorylcholine (PC)-specific human µ heavy chain were cultured as described
For the analysis of cytokines duplicate samples were isolated on day 4, and expression of IL-4 and IFN-γ was of EtxB, MACS purified splenic B220 ϩ cells were incubated with 0.5, 1, 10, 30, 80, 160 and 320 (not shown) µg/ml of determined.
either EtxB or EtxB (G33D) , in the presence of sodium azide Assay for secreted cytokines and on ice. Following washing, the presence of bound EtxB or EtxB (G33D) was determined by flow cytometry. In comparison A cell-based sandwich ELISA method for measuring cytokine with EtxB, little or no binding of EtxB (G33D) was detected in levels of IL-2, IL-4, IL-5 and IFN-γ was used, as described the range of 0.5-10 µg/ml (Fig. 1 ). This agrees with previous previously (36) . Briefly, duplicate 0.1 ml samples of cells were reports on the inability of EtxB (G33D) to bind GM 1 on B cells transferred under sterile conditions to wells coated with anti- (31) , to plastic dishes coated with GM 1 (18) or to other cells cytokine-specific antibody. Cells were incubated overnight at including T cells (T. O. Nashar, unpublished). Within this 37°C and then washed. Plates included wells to which a serial dose range, EtxB binding demonstrates two populations with dilution of standard cytokines was added. To detect secreted different densities of GM 1 and representing precursor versus cytokines, biotinylated anti-cytokine antibodies followed by mature B cells. addition of Extravidine-peroxidase and tetramethylbenzidine
In contrast to the specific binding activity of EtxB in the as substrate were used. The level of each cytokine in the test dose range of 0.5-10 µg/ml, higher doses (30-320 µg/ml) samples was determined by PROBIT regression analysis from resulted in the binding of both EtxB and EtxB (G33D) . The nonstandard cytokines.
specific adherence occurring at that concentration is likely Labelling of isolated B cells for cell-surface markers due to increased hydrophobicity of these antigens. Similar results were obtained in independent experiments using Splenic B220 ϩ cells were isolated as described above. Culbiotinylated EtxB and EtxB (G33D) and B cell lines (not shown). tures were established at 2ϫ10 6 /ml in complete medium to
To investigate GM 1 -mediated antigen presentation of EtxB, which 0.5% MAS was added. Cells were cultured in the splenic B220 ϩ cells were pulsed with 1, 10, 30, 80 or 160 presence or absence of 40 µg/ml of EtxB or EtxB (G33D) for 48 µg/ml of either EtxB or EtxB (G33D) for 24 h. Following washing, h. They were washed, counted, and then labelled on ice 6ϫ10 5 pulsed B cells were incubated with 1.25ϫ10 6 EtxBwith PE-anti-B220 and FITC-conjugated antibodies directed primed CD4 ϩ T cells, and the T cell proliferation and cytokine against MHC class II, B7-2, CD40 and ICAM-1. Controls response was measured after 4 days. At all doses examined, included unlabelled cells from cultures incubated with EtxB or presentation of EtxB was more effective than EtxB (G33D) ( EtxB resulted in significantly greater proliferation than B220 ϩ cells.
EtxB (G33D) suggesting that specific binding of EtxB to GM 1 Conjugation of OVA results in improved antigen processing and/or presentation. The experiment was also performed with a fixed concentration OVA (Sigma) was reduced with DTT to expose SH groups of antigen and increasing cell number. Splenic B cells were and run on a Sephacryl 300 column to separate out nonisolated and incubated with 80 µg/ml of either EtxB or monomeric fractions. Fractions were pooled and dialysed EtxB (G33D) . Cells were washed and then incubated at increasagainst PBS until the OVA:SH ratio was 2.0. The number of ing concentration with EtxB-primed CD4 ϩ T cells. Presentation SH groups was determined by the Ellman assay. To conjugate of pulsed B cells was significantly more effective than that of OVA to EtxB, EtxB was reacted with GMBS (Pierce) at a 1:4 EtxB (G33D) , with increasing T cell proliferation correlating with molar ratio and loaded on G25 column to separate out excess increasing B cell number (Fig. 2B) . of GMBS. Subsequently, OVA was mixed with EtxB-GMBS at Analysis of the cytokine profile in these cultures demon-1:1 molar ratio. The reaction was stopped with 50 mM β-strated that presentation of each of the antigens induced mercaptoethanol. The mixture was run on Sephacryl 300 secretion of IL-2, IL-4 and IL-5 without detectable IFN-γ ( It is noteworthy that the results in Fig. 2(A and B) represent column to obtain the retention volume that was used to direct effects of EtxB on B cells and were not complicated determine the molecular weight. The ratio of EtxB:OVA was by EtxB effects on T cells as the APC were thoroughly washed estimated to be 1:2.7.
following incubation with the antigens. Further, the detectable OVA was conjugated to PC as described (34) .
higher levels of IL-2 in cultures containing EtxB supports that T cells were responsible for the observed proliferation in these Results cultures. We conclude that specific binding of GM 1 by EtxB on primary B cells enhances the presentation of EtxB to CD4 ϩ GM 1 
-mediated antigen presentation by B cells enhanced
T cells, resulting in greater T cell proliferation and cytokine efficiency of presentation of EtxB to CD4 ϩ T cells production. The priming with EtxB in vivo induces an EtxB-specific recall
Binding of EtxB up-regulates expression of MHC class II response in lymph node cell culture (18). Therefore, we investigated whether GM 1 -mediated presentation by purified To investigate possible mechanisms responsible for the enhanced GM 1 -mediated presentation of EtxB in primary B B cells was essential for the EtxB-induced proliferation.
In order to examine the binding properties of various doses cells, the effects of EtxB and EtxB (G33D) on the expression of co-stimulatory molecules including MHC class II, B7-2, CD40 expression of class II that contribute to EtxB enhanced presentation. and ICAM-1 were examined. Incubation with EtxB, but not EtxB (G33D) resulted in increased expression of MHC class II Binding to GM 1 targets EtxB to MHC class II-rich com- (Fig. 3) . However, there were no effects of EtxB or EtxB (G33D) partments on the other B cell co-stimulatory molecules (not shown). Similar results were found regardless of whether splenic B While EtxB-induced up-regulation of MHC class II can cells were purified by either positive or negative selection.
enhance antigen presentation, we also examined whether Despite the lack of effects on co-stimulatory markers other binding to GM 1 results in improved internalization and targetthan class II, the addition of EtxB to lymphocyte cultures ing to class II-rich compartments. resulted in increased expression of CD25 on B cells (28, 29) .
In murine A20 B cells containing a transfected PC-specific Increased expression of CD25 by EtxB would result in activahuman µ surface Ig, internalization and processing of BCR tion of B cells following binding its ligand IL-2. Similarly, bound antigens occurs in class II-rich early and late endosoexpression of higher level of class II would result in expression mal compartments of CIIV and MIIC respectively (34, 35) . To of higher density of T cell ligands. Thus EtxB-GM 1 interaction examine whether GM 1 -mediated uptake targets efficiently EtxB to the same class II-rich compartments, A20µWT results in the activation of B cells including their higher 5 ) or increasing numbers of these cells were incubated with increasing doses (A) or with 80 µg/ml (B) of either EtxB or EtxB (G33D) . Cells were washed and incubated with 1.25ϫ10 6 pure MLN CD4 ϩ T cells, isolated from mice previously immunized with EtxB. Representative proliferation results from these cultures are shown on day 4, when maximum response was detected. Cytokine secretion was examined under conditions where proliferation was maximum, i.e. at higher doses of 80 µg/ml of EtxB and EtxB (G33D) , and on day 4 (C). All cells we pulsed with 1 µCi/well of [ 3 H]thymidine in the last 6 h before harvesting and counting by standard liquid scintillation. Data on proliferation represent mean of triplicate samples Ϯ SEM. Data on cytokines represent mean values of duplicate samples Ϯ variance extrapolated from a standard curve generated for each of the cytokines.
in these cells either under conditions where the hµ was crosslinked with 100 µg/ml of PC-OVA conjugate (Fig. 4a-e) or in the absence of the latter (Fig. 4f) . The conjugate was added in the last 20 min of incubation of B cells with EtxB on ice. Cells were then homogenized and total cell membranes were fractionated on continuous Nycodenz gradients as previously described (35) . PC-specific hµ, class II and EtxB were subsequently detected by incubating subcellular fractions with anti-hµ-HRP and biotinylated anti-I-A d specific antibodies and with Ultravidin-HRP (class II and EtxB).
As shown in Fig. 4 , class II activity was detected within two major compartments between fractions 4-9 (late endosomes) and 14-20 (plasma membrane and CIIV) as described (35) . The distribution of class II in fractions 5-9 represents the class II that is rich in cathepsin B and contains low levels of the enzymatically active form of the lysosomal enzyme β hexoaminidase (35) . The position of the plasma membrane coincides with that of hµ [(35) fractions 14-17 in this study (see below)]. On the other hand, CIIV is an early endosomal compartment (34, 35) that displays lower class II activity and is identified by its putative marker protein (i.e. p50 Iga ). After 20 min internalization at 37°C a portion of hµ was 2ϫ10 6 /ml with 40 µg/ml of either EtxB or EtxB (G33D) . After 48 h cells present in CIIV and late endosomes, with the remainder on the were harvested, washed, counted, and then labelled with PE-anticell surface (Fig. 4b ) similar to that previously reported (34, 35) . internalization of biotinylated EtxB was examined in A20 cells, in the presence of PC-OVA, 20, 60 and 120 min at 37°C (Fig.  4c-e) . As early as 20 min after incubation, EtxB was detected in fractions 2-12 and 15-19 corresponding to late endosomes (A20 cells transfected with IgM anti-PC) were incubated with and plasma membrane/CIIV respectively. After 60 min, frac-1 µg/ml of biotin-labelled EtxB initially for 20 min on ice, and tions 4-9 and 14-20 still had detectable activity of EtxB, but then for a further 20, 60 and 120 min. Using biotin-labelled with the appearance of high level of activity in fraction 11. EtxB (G33D) no non-specific binding of antigen to A20µWT occurred (not shown). Internalization of EtxB was examined
The appearance of the latter peak was not consistent in two PC-OVA (100 µg/ml) was added to cells in the last 20 min following incubation of EtxB on ice. To examine internalization of EtxB in the absence of hµ effects (f) cells were incubated with EtxB for 20 min at 37°C, as described above. Non-internalized antigen was washed off and the cells were homogenized and ruptured by nitrogen cavitation as described (34) . Subcellular components were then separated from nuclei and intact cells by centrifugation, and subsequently overlaid on a discontinuous Nycodenz gradient made of 8, 16 and 24%. Aliquots of 50 µl from collected fractions were dried onto ELISA plates and probed with biotin-anti-class II (I-A d ) and goat anti-µ-peroxidase conjugate. Class II and EtxB were subsequently detected with Ultravidine-peroxidase. Data are expressed as percentage of total activity in all fractions. Fractions represent class II-rich early endosomes (CIIV), plasma membrane (PM) and late endosomes (MIIC), as previously described (35) .
out of three similar experiments. After 120 min, the bulk of labelled EtxB initially for 20 min on ice and then for an additional 20 min at 37°C. Fractionation of the cells and the remaining EtxB activity was present in late endosomes. The activity in fractions collected at '0' min (37°C) followed detection of EtxB activity in the subcellular fractions were performed as described above. Consistent with the results in similar distribution as described for 20 min incubation of the cells with EtxB (not shown). This rapid internalization of EtxB Fig. 4(a and c) , high levels of activities of EtxB and MHC class II were detected in the late endosome and plasma is likely induced by its capping surface GM 1 .
The results demonstrate that binding of EtxB to GM 1 enables membrane/CIIV as early as 20 min after incubation at 37°C. These were detected in fractions 4-6 and 17-20 respectively. it to enter effectively MHC class II-rich compartments. Further, the pattern and the kinetics by which EtxB was distributed in
The results suggest that effective access of EtxB into the class II-rich compartments is independent of cross-linking hµ. the various fractions suggests a progressive access of EtxB from an early to a late compartment that represent CIIV and GM 1 -mediated antigen presentation by CD11c ϩ DC MIIC respectively.
As hµ internalization may influence uptake and targeting of Having shown above that GM 1 -mediated presentation of EtxB by B cells effectively enhanced its presentation, we EtxB, we examined whether EtxB could access the class IIrich compartment in the absence of any effects from the latter examined its presentation by DC that are known to be potent APC. (Fig. 4f) . A20µWT cells were incubated with 1 µg/ml of biotin- 
Binding to GM 1 on DC significantly enhances presentation of EtxB to CD4 ϩ T cells
To investigate the role of GM 1 in presentation by DC, CD11c ϩ cells were isolated from MLN and incubated with 0.5, 0.1 or 1 µg/ml of EtxB or EtxB (G33D) . Adherent cells were subsequently washed to remove non-internalized antigens and were mixed with CD4 ϩ T cells isolated from mice injected with EtxB in incomplete Freund's adjuvant. As shown in Fig. 5 , presentation of EtxB by DC resulted in a significant increase in the level of T cell proliferation compared with equivalent doses of EtxB (G33D) . In concert with increased T cell proliferation, EtxB presentation resulted in augmented IFN-γ and IL-4 production.
Improved GM 1 -mediated presentation of EtxB can be exploited to enhance presentation of other antigens.
To examine whether the improved presentation of EtxB could be exploited to enhance uptake and targeting of other soluble overnight incubation of the APC with OVA-responsive DO.11, proliferation of IL-2-responsive HT-2 cells was determined. Results from these experiments (Fig. 6) show that the presentation of OVA was significantly enhanced when conjugated their efficient delivery into the pathways of antigen processing and presentation. to EtxB. The activation of OVA-responsive T cells following presentation of OVA conjugated to EtxB (G33D) or free OVA was similar to those of the medium control. Under these Discussion experimental conditions (2 h incubation at 37°C, up to 60 µg/ml of OVA) a response to OVA above background was
The role of GM 1 in antigen presentation was examined by comparing the effects of EtxB, a protein with high affinity for not detected. It is noteworthy that the addition of EtxB with non-conjugated OVA had no effects on its kinetics GM 1 , versus those of a non-binding variant, EtxB (G33D) . We demonstrated that binding of EtxB to APC is intimately involved of processing and presentation (not shown). Thus, GM 1 -meditated uptake of proteins conjugated to EtxB results in in several aspects of antigen presentation, including uptake and internalization of antigen into MHC class II-rich comparttion by B cells results in the secretion of predominatly T h 2 ments, and expression of MHC II on APC, with a resulting cytokines (47) . The expression of higher densities of peptideaugmentation in T cell proliferation and cytokine production.
MHC complexes on B cell surfaces has been shown to result The involvement of GM 1 in antigen processing and presentain augmented IL-4 production relative to IFN-γ (48) . tion was further demonstrated by efficient presentation of Events subsequent to the binding of EtxB and its related additional antigens such as OVA when coupled to EtxB.
toxins are not fully elucidated. However, GM 1 is involved How does antigen uptake through GM 1 lead to more in mediating internalization of Ctx through cholesterol and effective presentation in B cells? First, binding to GM 1 results glycolipid-rich microdomains in the cell membrane (8) . Morein enhanced rate of uptake. B cells can internalize any over, internalization of CtxB and Ctx involves an actin-based soluble antigen by pinocytosis, subsequently processing and cytoskeleton and is mediated through non-coated pits (9,49). presenting them as peptide-MHC complexes to T cells (37) .
Using subcellular fractionation techniques, we showed here However, pinocytic antigen uptake is inefficient and large that binding of EtxB to GM 1 results in its rapid internalization amounts of antigen are ultimately required. Specific receptors and targeting to MHC class II-rich compartments MIIC and on B cells, macrophages and DC (BCR, Fc receptor, comple-CIIV, previously shown to be involved in the processing of ment receptor, scavenger or mannose/fucose family of recepexogenous antigen (35, 50) . tors) bind and internalize antigens much more efficiently (1,2) .
The results in Fig. 4 regarding the distribution of class II, Presumably antigen uptake by these receptors is essential internalized hµ and EtxB suggest that both CIIV and MIIC when the dose of antigen is limited. However, while binding are efficiently accessed by EtxB, and that EtxB eventually to surface receptors mediates efficient antigen presentation, accumulates in the latter. It is noteworthy that although ligation of some receptors interferes with APC activation.
internalization of EtxB into the class II-rich compartments was Thus, antibodies that cross-link sIg and FcγRII receptors on found to be independent of hµ cross-linking, internalization B cells also recruit tyrosine phosphatases, and thereby inhibit of hµ appears to enhance GM 1 access into the class II normal BCR signalling (38, 39) . Similarly, other receptors such compartments (41) . This raises the interesting possibility that as CD19 and CD22 either amplify or restrict T-dependent EtxB and CtxB (which was used as a marker in the previous responses respectively (40) . Although binding to surface study) may differ in the way they are internalized. In this receptors can lead to improved antigen internalization, this regard, it is well documented that EtxB, unlike CtxB, not only alone is not sufficient to ensure efficient antigen presentation.
binds to GM 1 but also binds weakly to glycoprotein receptors Thus, binding of CtxB to GM 1 on B cells did not necessarily (11). The contribution of these receptors in EtxB internalization result in its internalization into class II-rich late endosomal remains to be determined. compartments (41) . Moreover, mutation of a single transmemFurther evidence implicating a role for GM 1 in antigen brane residue that disrupted normal BCR sorting resulted in presentation is provided by the experiments involving the efficient uptake, but unproductive antigen degradation (42) , presentation of EtxB by CD11c ϩ DC (Fig. 5) . Thus, the indicating that internalized antigens do not necessarily access differences in the level of T cell proliferation between EtxB and class II MHC compartments following endocytosis.
EtxB (G33D) again suggests more effective antigen presentation An important role of GM 1 in antigen uptake is suggested when bound to GM 1 . Potential mechanisms for the enhanced by the finding that small doses of EtxB (0.5-10 µg/ml) bound antigen presentation include augmented targeting of bound to B cell surfaces were efficiently presented while comparable antigen, or effects on the expression of surface molecules concentrations of the non-binding mutant EtxB (G33D) were not [e.g. MHC class II on B cells (Fig. 3) ]. However, CD11c ϩ (Figs 1 and 2) . Moreover, GM 1 -mediated events occurring at cells isolated from lymph nodes express intrinsically high higher doses of EtxB (30-160 µg/ml) may also contribute levels of MHC I and II, and abundant accessory molecules to effective antigen presentation. Thus, B cells exhibited such as CD54, CD40 and CD86 (51). The findings therefore increased MHC II expression, and augmented T cell suggest that the enhanced presentation of EtxB results from responses at high doses of EtxB (Figs 1-3) . The effects of more effective targeting and access to compartments of high doses are unlikely to be attributable to the detectable antigen processing and MHC loading. small amounts of LPS in EtxB preparations. This is because
The findings above implicate GM 1 in immune cellular events both EtxB and EtxB (G33D) samples contained comparable including uptake and presentation, cytokine secretion, and amounts of this mitogen, and optimal activation of B cells was generation of downstream cell signals. In this study we used achieved by much greater concentration of LPS (50 µg/ a mutant protein of EtxB that is unable to bind to GM 1 on a ml) (29) .
variety of cells or in a GM 1 ELISA. However, as a specific Enhanced expression of MHC class II has also been antibody to GM 1 is currently unavailable we cannot rule out reported following incubation of B cells with the closely related binding of EtxB to other receptors, albeit with much lower proteins, CtxB (43) and Ctx (23). These secondary effects of affinity (11). Further, due to the wide distribution of GM 1 on GM 1 ligation may be explained by recent findings that GM 1 -various type of cells involved in an immune response in vivo, containing glycolipid microdomains in the membrane are it is likely that the outcome of presentation of bound antigens associated with signalling molecules such as Lck, Fyn and is determined not only by the APC but also by their regulatory Lyn, and may mediate signalling events in B and T cells effects on other cells and their products. For example, binding (44) (45) (46) .
of EtxB to CD8 ϩ T cells induces their depletion in proliferating The finding that EtxB presentation by B cells induces the cultures by apoptosis (18,28). Nevertheless, the experiments secretion of IL-2, IL-4 and IL-5, but not IFN-γ (Fig. 2C) , is consistent with previous observations that antigen presentainvolving pre-incubation of APC with EtxB strongly suggest
